# Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer

> **NCT02948751** · — · COMPLETED · sponsor: **Columbia University** · enrollment: 14 (actual)

## Conditions studied

- Breast Cancer
- Leptomeningeal Metastasis

## Interventions

- **DEVICE:** OncoCEE

## Key facts

- **NCT ID:** NCT02948751
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-06
- **Primary completion:** 2019-12-18
- **Final completion:** 2019-12-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02948751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02948751, "Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02948751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*